Adicet Bio, Inc.

NASDAQ:ACET

Biotechnology

Healthcare
$5.53 +0.25%

+$0.02 today

Market cap
$51.70M
Beta
1.57
P/E (TTM)
-0.8
EPS (TTM)
-$10.13
52W Low $6.01High $17.44

Volume 0.15M

Average 0.12M

ACET Property, Plant & Equipment (Net)

Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.

Adicet Bio, Inc.NASDAQ: ACET

Property, Plant & Equipment (Net) · Q1 FY2026 · quarter ended Mar 2026

Property, plant & equipment (net) falls 23.6% from a year ago

Property, plant & equipment (net) stood at $26.36M at the end of Q1 FY2026, down 23.6% from a year earlier and down 7.4% from the prior quarter. Over 3 fiscal years it compounded at -16.5% a year.

Context

  • Property, plant & equipment (net) amounted to 15.6% of total assets at the end of Q1 FY2026, down 2.5 pp from a year earlier.
  • Property, plant & equipment (net) increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether property, plant & equipment (net) keeps falling in the next quarterly balance sheet after a -23.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$26.36M-7.4% QoQ
Last fiscal yearDec 2025
$28.48M-22.5% YoY
Year agoMar 2025
$34.49M-23.6% since
Property, Plant & Equipment (Net) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-23.6%——
1 year-22.5%——
3-year CAGR-16.5%——
5-year CAGR——
10-year CAGR——

Property, Plant & Equipment (Net) history

USD · from the balance sheet

Latest · FY2025
28.48M USD
Year-over-year change
-22.5%
4-year CAGR
-5.0%

Property, Plant & Equipment (Net) vs competitors

How ACET compares with its peers on the latest reported figures

  • ACET's Mar 2026 property, plant & equipment (net) of $26.36M is the 2nd highest of the 8 companies compared; the peer median is $983K.
  • Its year-over-year change of -23.6% is the 4th highest of 7, against a peer median of -24.8%.
  • Property, plant & equipment (net) amounts to 15.6% of total assets for ACET, versus a peer median of 5.2%.
ACET Competitors Peer median
Property, Plant & Equipment (Net) for ACET and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TCRXTScan Therapeutics, Inc.Mar 2026$64.13M -9.8%-1.3%31.7%
ACETAdicet Bio, Inc.Mar 2026$26.36M -23.6%-16.5%15.6%
ACRVAcrivon Therapeutics, Inc. Common StockMar 2026$6.91M -13.5%+2.6%6.4%
HOWLWerewolf Therapeutics, Inc.Jun 2026$1.26M -88.6%-17.2%5.2%
IMUXImmunic, Inc.Mar 2026$983K -36.2%-13.8%0.5%
NRXPNRx Pharmaceuticals, Inc.Mar 2026$936K ——7.9%
ADAGAdagene Inc.Dec 2025$862.91K -38.8%-33.8%1.1%
GANXGain Therapeutics, Inc.Mar 2026$355.01K +26.3%-20.2%1.9%
Peer median (excluding ACET) $983K-24.8%-15.5%5.2%

Competitors are the stored peer set for ACET. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents277.54M257.66M159.71M56.5M38.92M
Short-term Investments000119.81M119.61M
Net Receivables214K435K00342K
Inventory00000
Other Current Assets2K336K457K474K320K
Total Current Assets282.44M261.04M162.27M180.14M160.93M
Property, Plant & Equipment (Net)35M48.98M44.2M36.75M28.48M
Goodwill19.46M19.46M000
Intangible Assets00000
Long-term Investments00002.87M
Tax Assets00000
Other Non-current Assets2.04M1.21M822K3.33M76K
Total Non-current Assets56.5M69.65M45.02M40.08M31.43M
Total Assets338.94M330.69M207.3M220.22M192.36M
Account Payables3.26M4.4M2.63M4.83M4.74M
Short-term Debt00000
Tax Payables00000
Deferred Revenue4.81M0000
Other Current Liabilities4.02M5.7M6.93M7.11M5.63M
Total Current Liabilities16.32M19.71M19.29M19.39M21.53M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities115K114K130K116K62K
Total Non-current Liabilities19.49M18.65M17.83M14.22M11.61M
Total Liabilities35.81M38.35M37.12M33.61M33.15M
Common Stock4K4K4K8K10K
Retained Earnings(168.32M)(238.11M)(380.77M)(497.89M)(614.7M)
Accumulated OCI00016K102K
Other Stockholders Equity00000
Minority Interest00000
Total Equity303.13M292.34M170.18M186.61M159.21M
Total Debt20.94M21.02M20.92M17.23M14.74M
Net Debt(256.6M)(236.63M)(138.79M)(39.26M)(24.18M)

Adicet Bio, Inc.

NASDAQ:ACET

Intrinsic Alpha fair value

Locked

Current Price

$5.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.